PETER BESSAS: Open Payments
NPI 1992756498 · VANCOUVER, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,114 in 44 payments from 10 companies in 2025. Trend: 2023 $631 · 2024 $121 · 2025 $1,114
Food & beverage: $1,114
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $320 |
| Axsome Therapeutics, Inc. | 9 | $228 |
| PFIZER INC. | 8 | $182 |
| Novo Nordisk Inc | 5 | $139 |
| Amgen Inc. | 2 | $57 |
| Lilly USA, LLC | 2 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| Madrigal Pharmaceuticals | 1 | $37 |
| Exact Sciences Corporation | 1 | $31 |
| Gilead Sciences, Inc. | 1 | $29 |
Products named: AIRSUPRA, NURTEC ODT, Auvelity, Ozempic, Sunosi, Wegovy, ZEPBOUND, CAPLYTA.
Industry payments across WA — which companies pay providers there.
